The first part of this paper describes how the concentration (0.37 -65.0 µg/l) of Be in undiluted urine samples can be directly determined by GFAAS after the urine sample was diluted (1+1) with a Nash reagent containing acetylacetone (0.2%, v/v) in ammonium acetate buffer of pH 6.0. The accuracy was tested with standard reference materials (SRM 2670 freeze-dried human urine). Selenium (Se) is an essential trace element in living organisms 2, 12 because Se acts as a cofactor in the glutathione peroxidase of cell membrane and is important in cellular detoxification of peroxides. 13 From the intake of daily food and drinking water, Se or its salts accumulates in kidneys, 12 liver, 12, 13 plasma, 14 blood, 14 and serum, [13] [14] [15] [16] [17] [18] [19] or is excreted in the urine. 15, [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] The normal levels of urine Se are in the range of 10 -100 µg/l, 7 but a concentration greater than 400 µg/l is considered toxic. 7 Several normal levels of serum Se are reported as follows: 80 -270 µg/l from the Clinical Guide Laboratory Test; 7 29 -139 µg/l from a review 17 by collecting the results of healthy subjects from Germany, France, Italy, Ireland, Switzerland, Hungary, Greece, USA, and Spain; 5 -160 µg/l from the Glasgow Royal Infirmary Trace Element Unit. 29 Smaller concentrations of Se may cause diseases, such as anemia, 30 heart disease, [13] [14] [15] [16] [17] 28 or cancer; 13, 28 whereas large concentrations of Se cause changes in diastolic blood pressure, 30 higher uric acid, 30 or gastrointestinal troubles. 17 Several techniques used for the determination of Se in human urine and serum are inductively coupled plasma-mass spectrometry (ICP-MS) after diluting samples; 15, 28 HPLC-ICP-MS for urine Se speciation [23] [24] [25] and hydride-generation atomic absorption spectrometry (HGAAS) after digesting samples with acids; 13, 20 flow-injection HGAAS; 14, 21 HPLC-HGAAS; 22 fluorometric detection; 19 constant current stripping analysis; 26 and GFAAS (or ETAAS); [16] [17] [18] or GFAAS after microwave 
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For human urine beryllium (Be), each sample (500 µl) was diluted (1+1) with Nash reagent (containing 0.2% (v/v) acetylacetone and 2.0 M ammonium acetate buffer at pH 6.0) and then a 20-µl volume of Triton X-100 (0.4%, v/v) aqueous solution was added. An aliquot (10 µl) of the diluted urine mixture was introduced into a graphite cuvette and was atomized according to a temperature program. The method detection limit (MDL, 3σ) for Be was 0.37 µg/l in the undiluted urine sample and the calibration graph was linear up to 65.0 µg/l. Calibration graphs were prepared by the standard addition method. Accuracies of 98.6 -102% were obtained when testing standard reference material (SRM 2670) freeze dried human urine samples. Precision (relative standard deviation, RSD) for urine Be was ≤2.3% (withinrun, n = 5) and was ≤3.0% (between-run, n = 3). For human urine and serum selenium (Se), samples (100 µl) were diluted with HNO3 (0.2%, v/v) to make a (1+1) dilution for urine analysis or a (1+4) dilution for serum analysis. An additional aliquot (10 µl) of Triton X-100 (0.1%, v/v) was added to each 200 µl of (1+1) diluted urine (or 20 µl of the Triton X-100 was added to each 500 µl of (1+4) diluted serum) sample. After the diluted sample mixture (10 µl) was introduced into a graphite cuvette, the corresponding chemical modifier (10 µl, containing Ni 2+ + Pd + NH4NO3 in HNO3 (0.2%, v/v)) was added to it and the mixture was atomized. The MDL (3σ) for Se in urine and in serum was 4.4 and 21.4 µg/l in undiluted sample, respectively, and the calibration graphs were linear up to 150 and 400 µg/l. Accuracies of urine Se were 98.9 -99.4% by testing SRM 2670 (NIST) urine standards with RSD (between-run, n = 3) within 2.9%; and that of serum Se was 97.2% when testing a certified second-generation human serum (No. 29, #664) with RSD (between-run, n = 3) of 1.4%. The proposed method can be applied easily, directly, and accurately to the measurement of Be and Se in real samples (including six urine Se and four serum Se from patients of Blackfoot Disease in Taiwan). digestion. 27 The second part of this paper describes how the contents of Se in urine (4.4 -150 µg/l) and serum (21 -400 µg/l) samples can be directly measured by GFAAS after (1+1) and (1+4) dilution with HNO3 (0.2%, v/v), respectively, and using appropriate amounts of Ni 2+ + Pd + NH4NO3 as the chemical modifier. The accuracies were tested with certified reference materials (SRM 2670 freeze-dried human urine and a second-generation biological human serum). The proposed method can be applied to the analysis of real samples (including six urine and four serum samples from the patients in Blackfoot Disease Treatment Center in Taiwan).
Experimental

Apparatus
A Hitachi Z-8000 graphite-furnace atomic absorption spectrophotometer, equipped with a Zeeman background corrector, was used for the atomic absorption measurement of Be at 234.9 nm (or of Se at 196.0 nm) with a slit width of 1.3 nm. Hollow cathode lamps of Be and Se (Hitachi Co., Japan) were operated at 10 mA and 12.5 mA, respectively. Uncoated graphite tube cuvettes (No. 180-7400, Hitachi Co., Japan) were purchased.
Reagents and solutions
All chemicals used were of analytical grade or better. Nitric acid (double distilled, Seastar Co., Canada) was used to prepare 0.2% HNO3 (v/v) with pure water (Barnstead NANOpure system). Stock standard solutions of 1000 mg/l for Be (Be(NO3)2·4H2O in 0.5 M HNO3) and for Se (SeO2 in 0.5 M HNO3) were purchased from Merck (Germany). Working standard solutions of Be and Se were prepared daily by diluting 10.0 mg/l of the corresponding standard solutions with 0.2% HNO3 (v/v). Sodium chloride was superpure grade (Merck) and Triton X-100 was from Sigma (USA). A Nash reagent containing 150 g ammonium acetate (Merck), 3.0 ml glacial acetic acid (99.99%, Aldrich), and 2.0 ml acetylacetone (Merck) per liter of aqueous solution (i.e., 2.0 M ammonium acetate buffer at pH 6.0 together with 0.2% acetylacetone (v/v)) was prepared weekly. Palladium nitrate [Pd(NO3)2·xH2O], nickel nitrate hexahydrate (99.999%), and ammonium nitrate (99.99%) were from Aldrich and were used to prepare chemical modifiers for Se.
Standard reference samples of freeze-dried human urine (SRM 2670, NIST, USA) contain a normal level ≤0.5 µg/l of Be and 30 ± 8 µg/l of Se; and an elevated level of 33 µg/l of Be and 460 ± 30 µg/l of Se after reconstitution in 20.0 ml of pure water.
The following two certified freeze-dried human serums were purchased. Seronorm Trace Elements Batch No. 116 (Nycomed Pharma As, Norway) contains (100 ± 6) µg/l of Se after reconstituion in 3.00 ml of pure water. A second-generation biological reference material (Department of Internal Medicine, University Hospital, Ghent, Belgium) 31 contains 1.05 ± 0.05 µg/g of Se (dry weight) after reconstitution in 1.00 ml of pure water.
Samples of human urine and serum
For Be test, two urine samples (#1, of about 1.2 l and #2, of about 1.5 l) were obtained by collecting urine for 24 h from two normal persons in cleaned polyethylene bottles and were refrigerated at -20˚C while not in use. For Se test, one urine sample (#3, of about 1.8 l) was obtained by collecting urine for 24 h from a normal person. Another six urine samples (#4 to #9) collected at one time (10 ml for urine Se measurements and another 10 ml for creatinine analysis, containing 36, 78, 88, 66, 48, and 38 mg/100 ml of creatinine, respectively) and four serum samples (#1 to #4) were obtained from patients in the Blackfoot Disease Treatment Center (Provincial Hsing-Yin Hospital, Pei-Men, Tainan County, Taiwan) through the help of Dr. Ming-Yuh Wang.
Analytical procedure for Be in urine
Since the concentrations of Be in the urine of two normal persons [about 0.042 µg/l, obtained from standard addition method (0 -40 µl of 200 µg/l of Be)] were below the method detection limit (0.37 µg/l in undiluted urine), one of them (urine sample #1) was used as the matrix of urine and calibration graphs were prepared by the following standard additions method. Five hundred microliters of urine sample #1 were pipetted into vials (10 ml) and various amounts of standard solutions of Be (0 -100 µl of 200 µg/l or 80 µl of 400 µg/l in HNO3 (0.2%, v/v)) and Nash reagent (400 -500 µl) were added to make a (1+1) dilution. In order to decrease the sample viscosity and to dispense the sample more evenly in the graphite cuvette, an additional aliquot of 20 µl Triton X-100 (0.4%, v/v) was added to each 1000 µl of (1+1) diluted sample. A NaCl (0.9%, w/v) solution 7 was correspondingly diluted and was used as a simulated blank for urine. A portion (10 µl) of the (1+1) diluted urine sample mixture, or the blank solution, was introduced into a graphite cuvette and atomized according to a temperature program (Table 1(a) ). Peak heights in absorbance were used for quantitative analysis. Real urine samples were diluted (1+1) with Nash reagent before adding Triton X-100 and then analyzing by the procedure described above. Analytical procedure for Se in urine and in serum Calibration graphs were prepared by pipetting 100 µl of SRM 2670 normal level human urine (or Seronorm Batch No. 116 human serum) reconstituted solution into vials (10 ml). Various amounts of HNO3 (0.2%, v/v) and a standard solution of Se (100 µg/l in HNO3 (0.2%, v/v)) were added to make a (1+1) dilution for urine, or a (1+4) dilution for serum sample, together with standard additions. Real samples of human urine (#3 to #9) were diluted (1+1), or human serum (#1 to #4) were diluted (1+4), with HNO3 (0.2%, v/v), respectively. An NaCl (0.9%, w/v) solution 7 was correspondingly diluted and was used as a simulated blank for urine and serum. An additional aliquot of 10 µl of Triton X-100 (0.1%, v/v) was added to each 200 µl of (1+1) diluted urine sample, or 20 µl of Triton X-100 (0.1%, v/v) was added to each 500 µl of (1+4) diluted serum sample. After the diluted sample mixture, or the blank solution (10 µl), was introduced into a graphite cuvette, the corresponding chemical modifier [10 µl, containing Ni 2+ (150 µg) + NH4NO3 (100 µg) + Pd (5.5 µg) in HNO3 (0.2%, v/v) for urine and Ni 2+ (25 µg) + NH4NO3 (100 µg) + Pd (3.7 µg) in HNO3 (0.2%, v/v) for serum] was added to it and the mixture was atomized according to a temperature program (Table 1(b) or 1(c) ).
Results and Discussion
For Be in urine
The effect of ramping ashing temperatures (from 600 -600 to 600 -1500˚C for 45 s) and atomization temperatures (2400 -2800˚C for 4 s) on absorbance with and without the chemical modifier was tested with 40 pg Be in 10 µl of (1+1) diluted urine sample. The results (Fig. 1) indicate that the sensitivity of absorbance for Be in urine is enhanced by a factor of 1.3 in the presence of the chemical modifier. When a ramping ashing temperature is higher than 600 -1200˚C for 45 s, the absorbance begins to decrease; and when atomization temperature increases from 2400 to 2800˚C for 4 s, the absorbance increases. Hence, suitable ramping ashing (600 -1200˚C) and atomization (2800˚C) temperatures were obtained as tabulated in Table 1 Following the proposed method, the MDL for Be was determined as the concentration corresponding to three times the standard deviation of twelve replicates using 10 µl of the (1+1) diluted urine mixture at the lowest concentration (1.0 µg/l) of the calibration graph. The MDL (3σ) of human urine
Be from the mean of seven determinations was found to be 0.18 ± 0.01 µg/l in the (1+1) diluted sample. This corresponds to 0.37 µg/l (or 3.7 pg) in the undiluted urine sample. The limit of detection (LOD, 3σ) values of Be reported and chemical modifiers used are compared as shown in Table 2 . The MDL value of Be obtained in this work is higher than 0.019 pg, 6 but is comparable to others 8,10,11 reported elsewhere. A typical calibration graph for Be from standard addition method is y = 9.27 × 10 Table 3 (a). The precision (RSD) for urine Be in within-run measurements (n = 5) is ≤2.3% and in betweenrun (n = 3) measurements is ≤3.0%.
Concentrations of Be in real urine samples (#1 and #2) from two normal persons were measured by the proposed method and were found to be N.D. (<0.18 µg/L of Be in (1+1) dilution). After spiking 4.00 and 8.00 ng of Merck Be in 500 µL of urine samples, respectively, the average recoveries from triplicates were 98.3 -103% with RSD within 2.5%. The proposed method uses acetylacetone to react with Be(II) in the presence of ammonium acetate buffer of pH 6.0 to form a chelate of beryllium acetylacetonate, 32, 33 which enhances the sensitivity for Be. The proposed method can be applied easily and accurately to the measurement of Be (0.37 -65.0 µg/l) in urine samples. The linear range covers the toxic level of >20 µg/l of Be in the urine. 7 
For Se in urine
The effect of final ashing temperatures (1100 -1500˚C for 15 s) and atomization temperatures (2400 -2800˚C for 4 s) on absorbance with and without the chemical modifier was tested with 0.62 ng of Se in 10 µl of (1+1) diluted urine sample. The results (Fig. 1) indicate that without the chemical modifier, Se is lost completely during pyrolysis. In the presence of the chemical modifier during ashing, absorbance increases from 1100 to 1300˚C for 15 s and decreases after 1400˚C. During atomization, the absorbance increases as temperature increases from 2400 to 2800˚C for 4 s. Hence, suitable ashing (1300˚C) and atomization (2800˚C) temperatures were obtained as tabulated in Table 1 200 µg)] on absorbance is shown in Fig. 2 by testing with 0.62 ng Se using the temperature program listed in Table 1 (b). When 10 µl of chemical modifier contains 5.5 µg of Pd and 100 µg of NH4NO3, the absorbance increases rapidly as Ni 2+ increases from 0 to 150 µg and becomes stable after 150 µg. Ni 2+ may form the stable complex (NiSe) 34 with Se and eliminate the interference from phosphorous containing molecules (PO and P2) in urine and serum. 35 Therefore, the sensitivity 36 for Se in the urine sample is enhanced. When the chemical modifier contains 150 µg Ni 2+ and 100 µg NH4NO3, the absorbance slightly increases as Pd increases from 0 to 5.5 µg and then decreases after 5.5 µg. Pd may form stable complexes (SePd 37, 38 and/or SePd2 34, 38 ) with Se and eliminate the phosphorousmolecular interference in urine and serum. 35 Therefore, the sensitivity for Se is enhanced. When the chemical modifier contains 150 µg Ni 2+ and 5.5 µg Pd, the absorbance slightly increases as NH4NO3 increases from 0 to 100 µg and then decreases after 100 µg. NH4NO3 may volatilize NaCl 36 in the urine and serum samples 7 and enhance the sensitivity for Se. Hence, a chemical modifier (10 µl) containing Ni 2+ (150 µg) + Pd (5.5 µg) + NH4NO3 (100 µg) in HNO3 (0.2%, v/v) was used for human urine samples in this work. The results of LOD for urine and serum Se obtained in this work (Table 2) are  comparable to those using Ni   2+ , 15, 18, 27 Pd, 18 Pd/Mg(NO3)2, 16, 18 Cu, 18 Ir, 18, 21 Ir/Mg(NO3)2 18 for urine and/or serum Se. Following the proposed method, the MDL was determined as the concentration corresponding to three times the standard deviation of twelve replicates using 10 µl of the (1+1) diluted urine at 14.3 µg/l of Se prepared from the normal level of SRM 2670 urine sample. The MDL (3σ) of human urine Se from the mean of four determinations was found to be (2.1 ± 0.2) µg/l in the (1+1) diluted sample. This corresponds to 4.4 µg/l (or 44 pg) of Se in the undiluted urine sample. The LOD values of urine Se reported and chemical modifiers used are compared as shown in Table 2 . The MDL value obtained in this work is comparable to those (using ICP-MS, 15 ,28 stripping analysis, 26 HGAAS, 20 HPLC-HGAAS, 22 HPLC-HG-ICP-MS, 23 FI-HG-ETAAS, 21 or, HPLC-ICP-MS 24, 25 ) reported elsewhere. A typical calibration graph for urine Se from standard addition method is y = 5.90 × 10 -4 x + 4.32 × 10 -4 and is linear up to 71.4 µg/l in (1+1) dilution (or 150 µg/l of Se in undiluted urine sample) with a correlation coefficient of 0.9990.
The accuracy of the proposed method was checked by testing 34.8 and 55.2 µg/l of Se in (1+1) diluted samples prepared from the elevated and normal levels of SRM 2670 urine standards with HNO3 (0.2%, v/v). The results of (98.9 -99.4)% were obtained from the mean of three determinations with RSD (between-run) within 2.9%, as tabulated in Table 2 (b). Real urine samples (#3 to #9) were measured by using the proposed method and were found to contain 24.6 ± 0.8, 23.7 ± 0.2, 55.9 ± 2.3, 16.0 ± 0.4, 33.8 ± 0.6, 18.1 ± 0.6, and 13.2 ± 0.6 µg/l of Se, respectively, in undiluted samples from triplicates. The RSD 27 After spiking Merck Se standard solutions (14.3 -28.6 µg/l) to three urine samples (#3, #4, and #5) in (1+1) dilution, the average recoveries from triplicates were 98.9 -102% with RSD within 4.6%. It is concluded that the proposed method provides an easy, accurate, and direct technique for the measurement of Se in (1+1) diluted urine samples using Ni 2+ (150 µg) + Pd (5.5 µg) + NH4NO3 (100 µg) as a chemical modifier.
For Se in serum
The effect of final ashing temperatures (1100 -1600˚C for 60 s) and atomization temperatures (2400 -2800˚C for 4 s) on absorbance with and without the chemical modifier was tested with 0.96 ng of Se in 10 µl of (1+4) diluted serum sample (prepared from Seronorm Trace Elements Batch No. 116). The results (Fig. 1) indicate that without the chemical modifier, Se is lost completely during pyrolysis. In the presence of the chemical modifier, absorbance increases from 1100 -1200˚C for 60 s and decreases after 1300˚C during ashing. During atomization, the absorbance increases as temperature increases from 2400 to 2800˚C for 4 s. Hence, suitable ashing (1200˚C) and atomization (2800˚C) temperatures were obtained as tabulated in Table 1(c) .
Similarly, the effect of chemical modifiers (10 µl, containing various amounts of Ni 2+ (0 -150 µg), Pd (0 -14.8 µg), and NH4NO3 (0 -300 µg)) on absorbance was compared by testing with 0.96 ng of serum Se using the temperature program (Table 1 (c)). Similar to Fig. 2 , a chemical modifier containing Ni 2+ (25 µg) + Pd (3.7 µg) + NH4NO3 (100 µg) was selected for human serum in this work.
The MDL of serum Se was determined similarly to that described in urine Se by using 10 µl of (1+4) diluted serum Table 2 . The MDL value obtained in this work is higher than 2.7 µg/l by ICP-MS, 15 but is comparable to others (HGAAS, 13 and ETAAS using Pd, 18 Ni 2+ , 18 Pd/Mg(NO3)2, 16, 18 Ir, 18 Ir/ Mg(NO3)2, or Cu 2+ , 18 as a chemical modifier) reported elsewhere.
Following the proposed method, a typical calibration graph for serum Se is y = 5.22 × 10 -4 x -8.30 × 10 -4 and is linear up to 76.9 µg/l in (1+4) dilution (or 400 µg/l in undiluted serum sample) with a correlation coefficient of 0.9995. The accuracy of the proposed method was checked by testing 28.5 µg/l of Se prepared from the second-generation human serum (No. 29, #664) at (1+4) dilution. The results of (97.2 ± 1.4)% were obtained from the mean of three determinations as listed in Table 3 (c). Real serum samples (#1 to #4) were analyzed by using the proposed method and were found to contain 234.5 ± 5.2, 248.6 ± 5.2, 143.0 ± 3.1, and 98.8 ± 0.5 µg/l of Se in undiluted samples, respectively, from triplicates. The RSD (within-run, n = 3) is within 2.2%. The concentrations of Se measured in four serum samples from these four patients in Blackfoot Disease Treatment Center are in the normal range of 80 -270 µg/l suggested by the Clinical Guide Laboratory Test. 7 However, the two higher serum Se values above exceed the range of values reported for healthy subjects by others (29 -139 µg/l 17 and 5 -160 µg/l). 29 After spiking Merck Se standard solutions (9.60 and 19.2 µg/l) to serum sample #4 at (1+4) dilution, the average recoveries from triplicates were 98.4 -102% with RSD within 2.9%. Thus, the proposed method can be applied easily, directly, and accurately to the measurement of Se in (1+4) diluted serum samples using Ni 2+ (25 µg) + Pd (3.7 µg) + NH4NO3 (100 µg) as a chemical modifier. 
